{site_meta && site_meta.display_name} Logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

RSS Feed for InvestorBrandNetwork (IBN)

BioMedNewsBreaks — Regentis Biomaterials Ltd. (NYSE American: RGNT) Advances European Commercial Launch Plans for GelrinC

June 8, 2026Regentis Biomaterials (NYSE American: RGNT) announced plans to begin European surgeon training activities in the third quarter of 2026 as part of preparations for the commercial rollout of GelrinC(R), its CE Mark-approved treatment for knee cartilage lesions. The hands-on program will provide orthopedic surgeons with practical experience using the company’s cell-free implant and is expected to begin at Humanitas Research Hospital in Milan, Italy, with additional sessions planned across Europe.


Have the Drivers of Gold Prices Now Changed?

June 8, 2026Investors in gold are currently wondering what has happened to the bullish trend of gold prices after the precious metal reached record highs in January above $5,500 an ounce and has since struggled to move past the $4,500 mark. What has changed, and should investors expect further pullbacks in the price of bullion?


A Next-Gen Intelligence Platform Operating at the Intersection of AI, Defense Technology, and Quantum Cybersecurity

June 8, 2026AINewsWire Editorial Coverage: The convergence of artificial intelligence, operational intelligence infrastructure and post-quantum cybersecurity is creating growing demand for specialized platforms capable of supporting mission-critical environments across government, defense, healthcare, public safety and enterprise sectors. As organizations increasingly modernize legacy infrastructure and prepare for evolving cybersecurity, operational and regulatory risks, demand may continue growing for AI-powered systems capable of transforming complex scientific and security-related datasets into actionable intelligence and resilient infrastructure solutions.


TechMediaBreaks – Xeriant, Inc. (OTCQB: XERI) NexBoard Achieves Highest ASTM E84 Class A Fire Rating

June 8, 2026Xeriant (OTCQB: XERI) announced that its NexBoard(TM) fire-resistant construction panel has achieved a Class A fire rating in ASTM E84 certification testing, the highest classification available under the widely recognized industry standard for evaluating flame spread and smoke development in building materials. The company said the certification validates years of product development and represents a key milestone in advancing NexBoard as an alternative to traditional drywall and other construction panels.


InvestorNewsBreaks – TransCode Therapeutics, Inc. (NASDAQ: RNAZ) to Host First R&D Webcast Highlighting Phase 2a Oncology Program

June 8, 2026TransCode Therapeutics (NASDAQ: RNAZ) announced it will host its first live virtual R&D webcast on June 18, 2026, to provide strategic, scientific and clinical updates across its development pipeline. The presentation will be anchored by the company’s recently initiated Phase 2a clinical trial of TTX-MC138 in circulating tumor DNA-positive colorectal cancer and will also include portfolio updates and discussion of its broader investment thesis.


BioMedNewsBreaks — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF)(Frankfurt: W1H) (WKN: A3EKSZ) Signs LOI to Advance ONC010 Development, Appoints VP of Corporate Finance

June 8, 2026This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising. Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) (WKN: A3EKSZ) announced it has entered into a non-binding letter of intent with Nanosoft Polymers as an initial step toward negotiating a services agreement supporting development of its exclusively licensed PNKP inhibitor technology, ONC010.


BioMedNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) to Showcase AI Drug Discovery Platform at Qdrant Vector Space Day 2026

June 8, 2026Oncotelic Therapeutics (OTCQB: OTLC) announced that its proprietary PDAOAI(TM) drug discovery and development platform will be featured during the Product & Engineering keynote at Qdrant Vector Space Day 2026 in San Francisco on June 11. Company executives will join Qdrant leadership to discuss how PDAOAI, operating on Qdrant infrastructure, has helped accelerate the development of two drug candidates from concept to investigational new drug filings in less than two years, significantly reducing the time and cost traditionally associated with pharmaceutical development.


InvestorNewsBreaks – Pinterest Inc. (NYSE: PINS) Gains Attention Following Report on $4 Billion AWS AI Investment Initiative

June 5, 2026Pinterest (NYSE: PINS) attracted investor attention following a Benzinga report by Shanthi Rexaline highlighting the company’s plans to invest approximately $4 billion over several years in a strategic partnership with Amazon Web Services (“AWS”). According to the report, the initiative is designed to strengthen Pinterest’s artificial intelligence capabilities, enhance content personalization and improve advertising performance across its platform.